Mindray Medical’s Q3 Financial Report Disappoints

Mindray Medical reported that its Q2 revenues rose 18% to $257 million, with non-GAAP net income up an equal 18% at $50 million. Unfortunately, those results were below analysts’ estimates. Also, a $10 million charge took EBITDA and net income lower than the prior year’s similar period. The charge derives from a pricing dispute with a supplier over costs for components of patient monitors sold in the US. More details.... Stock Symbol: (NYSE: MR) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});